Regencell Bioscience Ownership 2024 | Who Owns Regencell Bioscience Now?
Institutional Ownership
0.01%
Insider Ownership
88.76%
Retail Ownership
11.23%
Institutional Holders
3.00
Regencell Bioscience Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.00% | - | 312 | -1,088 | -77.71% | 1,048 | Jun 30, 2024 |
BLACKROCK INC. | 0.00% | - | 238 | - | - | 800 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 13 | - | - | 44 | Jun 30, 2024 |
Regencell Bioscience's largest institutional shareholder is UBS GROUP AG, holding 0.00% of the company's total share outstanding, currently valued at $1.05K. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.00% | - | 312 | -1,088 | -77.71% | 1,048 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 13 | - | - | 44 | Jun 30, 2024 |
BLACKROCK INC. | 0.00% | - | 238 | - | - | 800 | Jun 30, 2024 |
The largest Regencell Bioscience shareholder by % of total assets is UBS GROUP AG. The company owns 312.00 shares of Regencell Bioscience (RGC), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKROCK INC. | 0.00% | - | 238 | - | - | 800 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 13 | - | - | 44 | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 312 | -1,088 | -77.71% | 1,048 | Jun 30, 2024 |
As of Jun 30 2024, Regencell Bioscience's largest institutional buyer is BLACKROCK INC.. The company purchased 0.00 stocks of RGC, valued at $800.00.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.00% | - | 312 | -1,088 | -77.71% | 1,048 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 13 | - | - | 44 | Jun 30, 2024 |
BLACKROCK INC. | 0.00% | - | 238 | - | - | 800 | Jun 30, 2024 |
As of Jun 30 2024, Regencell Bioscience's biggest institutional seller is UBS GROUP AG. The company sold -1.09K shares of RGC, valued at $1.05K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Regencell Bioscience Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
Gabelli Gold Fund, Inc. | 4.75% | 3,650,000 | - | - | Dec 29, 2023 |
AMERICAN CENTURY ETF TRUST | 0.00% | 100 | - | - | Feb 29, 2024 |
Regencell Bioscience's largest mutual fund holder by % of total assets is "Gabelli Gold Fund, Inc.", owning 3.65M shares, compromising 4.75% of its total assets.
Regencell Bioscience Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 3 | - |
31 Dec, 23 | 3 | -25.00% |
30 Sep, 23 | 4 | 100.00% |
30 Jun, 23 | 2 | -50.00% |
31 Mar, 23 | 4 | 33.33% |
31 Dec, 22 | 3 | -40.00% |
30 Sep, 22 | 5 | - |
30 Jun, 22 | 5 | 25.00% |
31 Mar, 22 | 4 | 100.00% |
31 Dec, 21 | 2 | -33.33% |
30 Sep, 21 | 3 | - |
As of 31 Mar 24, 3 institutions are holding Regencell Bioscience's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 1,651 | -89.87% |
31 Dec, 23 | 16,304 | 2362.84% |
30 Sep, 23 | 662 | 22.82% |
30 Jun, 23 | 539 | -26.77% |
31 Mar, 23 | 736 | -38.05% |
31 Dec, 22 | 1,188 | -85.51% |
30 Sep, 22 | 8,201 | -3.56% |
30 Jun, 22 | 8,504 | -57.99% |
31 Mar, 22 | 20,245 | 188.88% |
31 Dec, 21 | 7,008 | -49.85% |
30 Sep, 21 | 13,973 | - |
Regencell Bioscience (RGC) has 1.65K shares outstanding as of 31 Mar 24, down -89.87% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 0.01% | 80.85% |
31 Dec, 23 | 0.13% | 460128.85% |
30 Sep, 23 | 0.01% | 28562.79% |
30 Jun, 23 | 0.00% | 12625.86% |
31 Mar, 23 | 0.01% | 6590.43% |
31 Dec, 22 | 0.01% | 223.27% |
30 Sep, 22 | 0.06% | 1432.99% |
30 Jun, 22 | 0.07% | 262.40% |
31 Mar, 22 | 0.16% | 5214.44% |
31 Dec, 21 | 0.06% | 453.85% |
30 Sep, 21 | 0.11% | - |
As of 31 Mar 24, Regencell Bioscience is held by 0.01% institutional shareholders, representing a 80.85% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | -66.67% |
30 Sep, 23 | 3 | 200.00% |
30 Jun, 23 | 1 | -50.00% |
31 Mar, 23 | 2 | - |
31 Dec, 22 | 2 | 100.00% |
30 Sep, 22 | 1 | -80.00% |
30 Jun, 22 | 5 | 25.00% |
31 Mar, 22 | 4 | 100.00% |
31 Dec, 21 | 2 | -33.33% |
30 Sep, 21 | 3 | - |
- institutional shareholders have increased their position in RGC stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 1 | - |
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 1 | - |
31 Dec, 22 | - | -100.00% |
30 Sep, 22 | 2 | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
31 Dec, 21 | - | - |
30 Sep, 21 | - | - |
1 institutional shareholders have reduced their position in RGC stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 3 | - | 1,651 | -89.87% | 0.01% | 80.85% | - | -100.00% | 1 | - |
31 Dec, 23 | 3 | -25.00% | 16,304 | 2362.84% | 0.13% | 460128.85% | 1 | -66.67% | - | - |
30 Sep, 23 | 4 | 100.00% | 662 | 22.82% | 0.01% | 28562.79% | 3 | 200.00% | - | - |
30 Jun, 23 | 2 | -50.00% | 539 | -26.77% | 0.00% | 12625.86% | 1 | -50.00% | - | -100.00% |
31 Mar, 23 | 4 | 33.33% | 736 | -38.05% | 0.01% | 6590.43% | 2 | - | 1 | - |
31 Dec, 22 | 3 | -40.00% | 1,188 | -85.51% | 0.01% | 223.27% | 2 | 100.00% | - | -100.00% |
30 Sep, 22 | 5 | - | 8,201 | -3.56% | 0.06% | 1432.99% | 1 | -80.00% | 2 | - |
30 Jun, 22 | 5 | 25.00% | 8,504 | -57.99% | 0.07% | 262.40% | 5 | 25.00% | - | - |
31 Mar, 22 | 4 | 100.00% | 20,245 | 188.88% | 0.16% | 5214.44% | 4 | 100.00% | - | - |
31 Dec, 21 | 2 | -33.33% | 7,008 | -49.85% | 0.06% | 453.85% | 2 | -33.33% | - | - |
30 Sep, 21 | 3 | - | 13,973 | - | 0.11% | - | 3 | - | - | - |
Regencell Bioscience Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Regencell Bioscience's stock was made by ANSCHUTZ PHILIP F on Feb 28 2018, selling 12,440,000 shares at $23.00 per share (valued at $286.12M).
Regencell Bioscience Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Regencell Bioscience Peer Ownership
RGC Ownership FAQ
Who Owns Regencell Bioscience?
Regencell Bioscience is owned by institutional shareholders (0.01%), insiders (88.76%), and public (11.23%). The largest institutional shareholder of Regencell Bioscience is UBS GROUP AG (0.00% of total shares) and the top mutual fund owner is Gabelli Gold Fund, Inc. (4.75% of total shares).
Who are the major institutional shareholders of Regencell Bioscience?
Regencell Bioscience's major institutional shareholders are UBS GROUP AG, BLACKROCK INC., and QUBE RESEARCH & TECHNOLOGIES LTD. The top five shareholders own together 0.00% of the company's share outstanding.
How many Regencell Bioscience shareholders are there?
As of Mar 2024, there are 3 institutional shareholders of Regencell Bioscience.
What percentage of Regencell Bioscience is owned by UBS GROUP AG?
UBS GROUP AG owns 312 shares of Regencell Bioscience, representing 0.00% of the company's total shares outstanding, valued at $1.05K (as of Jun 2024).
What percentage of Regencell Bioscience is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 238 shares of Regencell Bioscience (RGC), compromising 0.00% of the company, valued at $800.
What percentage of Regencell Bioscience is owned by QUBE RESEARCH & TECHNOLOGIES LTD?
QUBE RESEARCH & TECHNOLOGIES LTD is the third largest holder of Regencell Bioscience. The company owns 13 of the company's shares outstanding (worth $44).